Skip Navigation LinksHome > November 2013 - Volume 19 - Issue 12 > Clonal Expansions and Short Telomeres Are Associated with Ne...
Inflammatory Bowel Diseases:
doi: 10.1097/MIB.0b013e3182a87640
Original Clinical Articles

Clonal Expansions and Short Telomeres Are Associated with Neoplasia in Early-onset, but not Late-onset, Ulcerative Colitis

Salk, Jesse J. MD, PhD*,†; Bansal, Aasthaa PhD; Lai, Lisa A. PhD†,§; Crispin, David A. BS*,†; Ussakli, Cigdem H. MD*; Horwitz, Marshall S. MD, PhD*; Bronner, Mary P. MD; Brentnall, Teresa A. MD†,§; Loeb, Lawrence A. MD, PhD*; Rabinovitch, Peter S. MD, PhD*,¶; Risques, Rosa Ana PhD*

Supplemental Author Material
Collapse Box

Abstract

Background:

Patients with ulcerative colitis (UC) are at risk of developing colorectal cancer. We have previously reported that cancer progression is associated with the presence of clonal expansions and shorter telomeres in nondysplastic mucosa. We sought to validate these findings in an independent case–control study.

Methods:

This study included 33 patients with UC: 14 progressors (patients with high-grade dysplasia or cancer) and 19 nonprogressors. For each patient, a mean of 5 nondysplastic biopsies from proximal, mid, and distal colon were assessed for clonal expansions, as determined by clonal length altering mutations in polyguanine tracts, and telomere length, as measured by quantitative PCR. Both parameters were compared with individual clinicopathological characteristics.

Results:

Clonal expansions and shorter telomeres were more frequent in nondysplastic biopsies from UC progressors than nonprogressors, but only for patients with early-onset of UC (diagnosis at younger than 50 years of age). Late-onset progressor patients had very few or no clonal expansions and longer telomeres. A few nonprogressors exhibited clonal expansions, which were associated with older age and shorter telomeres. In progressors, clonal expansions were associated with proximity to dysplasia. The mean percentage of clonally expanded mutations distinguished early-onset progressors from nonprogressors with 100% sensitivity and 80% specificity.

Conclusions:

Early-onset progressors develop cancer in a field of clonally expanded epithelium with shorter telomeres. The detection of these clones in a few random nondysplastic colon biopsies is a promising cancer biomarker in early-onset UC. Curiously, patients with late-onset UC seem to develop cancer without the involvement of such fields.

Copyright © 2013 Crohn's & Colitis Foundation of America, Inc.

You currently do not have access to this article.

You may need to:

Note: If your society membership provides for full-access to this article, you may need to login on your society’s web site first.

Login

Search for Similar Articles
You may search for similar articles that contain these same keywords or you may modify the keyword list to augment your search.